Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer

Clinical trial NCT07067749 · RECRUITING

Trial details

NCT number: NCT07067749
Sponsor: University of Rome Tor Vergata
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Bladder (Urothelial, Transitional Cell) Cancer Bladder Cancer Requiring Cystectomy Bladder Carcinoma Bladder Neoplasm Muscle Invasive Bladder Cancer (MIBC)

Start date: 2025-08-15
Primary completion: 2028-08-15
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.